125 related articles for article (PubMed ID: 8959993)
1. Excitotoxicity in ALS.
Leigh PN; Meldrum BS
Neurology; 1996 Dec; 47(6 Suppl 4):S221-7. PubMed ID: 8959993
[No Abstract] [Full Text] [Related]
2. Excitotoxicity hypothesis.
Rothstein JD
Neurology; 1996 Oct; 47(4 Suppl 2):S19-25; discussion S26. PubMed ID: 8858047
[No Abstract] [Full Text] [Related]
3. Sterol regulatory element binding protein-1 (SREBP1) activation in motor neurons in excitotoxicity and amyotrophic lateral sclerosis (ALS): Indip, a potential therapeutic peptide.
Taghibiglou C; Lu J; Mackenzie IR; Wang YT; Cashman NR
Biochem Biophys Res Commun; 2011 Sep; 413(2):159-63. PubMed ID: 21871872
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the therapy of amyotrophic lateral sclerosis: focus on excitotoxicity.
Brighina L; Sala G; Ceresa C; Tremolizzo L; Ferrarese C
Funct Neurol; 2001; 16(4 Suppl):189-202. PubMed ID: 11996516
[No Abstract] [Full Text] [Related]
5. Neurofilaments, free radicals, excitotoxins, and amyotrophic lateral sclerosis.
al-Chalabi A; Powell JF; Leigh PN
Muscle Nerve; 1995 May; 18(5):540-5. PubMed ID: 7739643
[TBL] [Abstract][Full Text] [Related]
6. [Neurotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients against some enzymes of glutamate metabolism].
Niebroj-Dobosz I; Janik P; Mickielewicz A; Jamrozik Z; Kwieciński H
Neurol Neurochir Pol; 2001; 35(1 Suppl):81-9. PubMed ID: 11732283
[TBL] [Abstract][Full Text] [Related]
7. Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: Implications for the role of astrogliosis in amyotrophic lateral sclerosis.
Zagami CJ; Beart PM; Wallis N; Nagley P; O'Shea RD
Glia; 2009 Jan; 57(2):119-35. PubMed ID: 18661557
[TBL] [Abstract][Full Text] [Related]
8. Hypothesis: gut as source of motor neuron toxin in the development of ALS.
Kaneko K; Hachiya NS
Med Hypotheses; 2006; 66(2):438-9. PubMed ID: 16236460
[No Abstract] [Full Text] [Related]
9. Excitotoxins and amyotrophic lateral sclerosis.
Munsat TL; Hollander D
Therapie; 1990; 45(3):277-9. PubMed ID: 2194313
[TBL] [Abstract][Full Text] [Related]
10. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis.
Rothstein JD
Adv Neurol; 1995; 68():7-20; discussion 21-7. PubMed ID: 8787245
[TBL] [Abstract][Full Text] [Related]
11. Advances in ALS workshop summary: Research and future goals.
Brooke MH; Strong MJ
Neurology; 1996 Oct; 47(4 Suppl 2):S108-12. PubMed ID: 8858063
[No Abstract] [Full Text] [Related]
12. Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis.
Vonk WI; Klomp LW
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1322-8. PubMed ID: 19021549
[TBL] [Abstract][Full Text] [Related]
13. Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?
Kawahara Y; Kwak S
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):131-44. PubMed ID: 16183555
[TBL] [Abstract][Full Text] [Related]
14. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis.
Nutini M; Frazzini V; Marini C; Spalloni A; Sensi SL; Longone P
Neuropharmacology; 2011 Jun; 60(7-8):1200-8. PubMed ID: 21056589
[TBL] [Abstract][Full Text] [Related]
15. Animal models of amyotrophic lateral sclerosis.
Mitsumoto H; Pioro EP
Adv Neurol; 1995; 68():73-87; discussion 89-91. PubMed ID: 8787246
[No Abstract] [Full Text] [Related]
16. Amyotrophic lateral sclerosis: fasting plasma levels of cysteine and inorganic sulfate are normal, as are brain contents of cysteine.
Perry TL; Krieger C; Hansen S; Tabatabaei A
Neurology; 1991 Apr; 41(4):487-90. PubMed ID: 2011244
[TBL] [Abstract][Full Text] [Related]
17. The role of AMPA receptors and VEGF in ALS.
Van Damme P
Verh K Acad Geneeskd Belg; 2009; 71(4):241-50. PubMed ID: 20084835
[TBL] [Abstract][Full Text] [Related]
18. Selective overexpression of gamma1 laminin in astrocytes in amyotrophic lateral sclerosis indicates an involvement in ALS pathology.
Wiksten M; Väänänen A; Liesi P
J Neurosci Res; 2007 Jul; 85(9):2045-58. PubMed ID: 17554784
[TBL] [Abstract][Full Text] [Related]
19. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis.
Rothstein JD
Clin Neurosci; 1995-1996; 3(6):348-59. PubMed ID: 9021256
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning.
Kumar V; Islam A; Hassan MI; Ahmad F
Eur J Med Chem; 2016 Oct; 121():903-917. PubMed ID: 27372371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
